Literature DB >> 6720361

New defects of pyrimidine metabolism.

S K Wadman, F A Beemer, P K de Bree, M Duran, A H van Gennip, D Ketting, F J van Sprang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6720361     DOI： 10.1007/978-1-4684-4553-4_19

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

Review 1.  When to investigate for purine and pyrimidine disorders. Introduction and review of clinical and laboratory indications.

Authors:  H A Simmonds; J A Duley; L D Fairbanks; M B McBride
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

2.  Inhibition of beta-ureidopropionase by propionate may contribute to the neurological complications in patients with propionic acidaemia.

Authors:  A H van Gennip; H van Lenthe; N G Abeling; E G Scholten; A B van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

3.  Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.

Authors:  R B Diasio; T L Beavers; J T Carpenter
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 4.  Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects.

Authors:  A H van Gennip; N G Abeling; P Vreken; A B van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 5.  Inborn errors of purine and pyrimidine metabolism.

Authors:  A Jurecka
Journal:  J Inherit Metab Dis       Date:  2009-03-15       Impact factor: 4.982

6.  Inborn errors of pyrimidine metabolism: clinical update and therapy.

Authors:  Shanti Balasubramaniam; John A Duley; John Christodoulou
Journal:  J Inherit Metab Dis       Date:  2014-07-17       Impact factor: 4.982
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.